Related Experiment Video
Updated: Jan 8, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Aberrant thalamic GABA-network coupling as a neural signature of insomnia severity in major depressive disorder
Yingying Huang1, Yi Xia2, Yiwen Wang1
1Nanjing Brain Hospital, Clinical Teaching Hospital of Medical School, Nanjing University, Nanjing 210029, China.
Abstract:
Insomnia is one of the most common and debilitating symptoms of major depressive disorder (MDD), with its severity closely associated with both the onset and course of the illness. However, its underlying neurobiological mechanisms remain poorly understood. This study employed a multimodal neuroimaging approach, combining magnetoencephalography and magnetic resonance spectroscopy, to separately examine the associations between insomnia severity and both thalamic functional connectivity (FC) with large-scale brain networks in the gamma frequency band, and thalamic gamma-aminobutyric acid (GABA) concentrations. Hierarchical regression analyses revealed a group-specific neurobiological mechanism, marked by opposing associations of insomnia severity with thalamic FC with large-scale brain networks and GABA⁺ levels between patients with MDD and healthy controls (HCs). Furthermore, the intrinsic coupling between thalamic GABA⁺ and thalamic-default mode network FC was reversed between groups, as evidenced by a negative association in HCs that trended toward a positive association in MDD patients. These findings indicate that insomnia in MDD constitutes a distinct pathological state, in which elevated thalamic GABA⁺ levels may represent a compensatory yet maladaptive response that disrupts thalamic GABA-network coupling. Our results provide a novel neurobiological framework for MDD-related insomnia and highlight the potential of therapies aimed at restoring thalamic neurochemical-functional coordination.
More Related Videos
05:19Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
Related Concept Videos
REM Sleep Behavior Disorder
RBD is significantly associated with...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
CNS Depressants: Barbiturates and Benzodiazepines
Depressive Disorders: MDD and Dysthymia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...